Study #2016-0860
A Phase 2 Study of Abemaciclib in Recurrent Glioblastoma
MD Anderson Study Status
Not Accepting
Treatment Agent
Abemaciclib
Description
This research study is studying a targeted therapy as a possible treatment for recurrent glioblastoma (GBM). The following intervention will be used in this study: -Abemaciclib
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Glioblastoma
Study phase:
Phase II
Physician name:
Vinaykumar Puduvalli
Department:
Neuro-Oncology
For general questions about clinical trials:
1-855-982-0789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.